Objective: Major depression is a common concomitant of chronic central nervous system disorders, notably Parkinson's disease (PD). Repetitive transcranial magnetic stimulation (rTMS) has been investigated as a potential treatment for depression in PD and for the movement disorder of PD, but comprehensive testing in multiple areas of performance has seldom been carried out within a single study. We studied the effect of left dorsolateral prefrontal rTMS on several different functional domains. Methods: Fourteen PD patients with treatment-resistant depression entered an open, 10-day inpatient study of 10-Hz rTMS, undergoing extensive psychiatric, neuropsychological, and motor testing from baseline to 6 weeks after treatment. Motor testing included a defined ''off'' state. Results: rTMS was well tolerated. Highly significant improvement in depression scores was seen 3 days and 3-6 weeks after treatment. Improvement was also found in anxiety, movement scores (especially in the off state), and some neuropsychological measures. We found no evidence of increased risk from rTMS in this population. Conclusions: Further controlled trials of rTMS in PD appear worthwhile, and should include a defined ''off'' state. Significance: TMS may be beneficial for depressed PD patients in multiple functional domains.
Introduction
Repetitive transcranial magnetic stimulation (rTMS) of the left dorsolateral prefrontal cortex (DLPFC) is a promising treatment for refractory depression (Berman et al., 2000; Epstein et al., 1998; George et al., 1997 George et al., , 1995 Grunhaus et al., 2003) . As rTMS becomes more widely used, determining whether it is effective in the setting of central nervous system (CNS) disorders will be important, because depression is a common concomitant of other CNS diseases. Clinical depression occurs in up to 50% of all patients with Parkinson's disease (PD) (Tandberg et al., 1996) , itself one of the most common CNS disorders, with a cumulative lifetime incidence above 1% and prevalence over 3% (Benito-Leon et al., 2003) . However, most experimental rTMS protocols have excluded patients with PD and other CNS disorders because of concerns about altered rTMS responsiveness and increased adverse effects.
The conjunction of depression and PD has special interest, because of the possibility that the psychomotor 
